How Does Retatrutide Work?

Retatrutide works by activating receptors for GLP-1, GIP and glucagon.

These are natural hormones involved in appetite, digestion, blood sugar and energy balance.

Retatrutide is described as a triple hormone receptor agonist, and informally referred to as “triple-G”.

The 3 hormones retatrutide acts on:

GLP-1: helps you feel fuller and eat less

GLP-1 is a natural gut hormone released after eating. It helps reduce appetite, slows down how quickly food leaves your stomach, and helps you feel full for longer.

This is why medicines that act on GLP-1 can help people eat less without feeling as hungry all the time.

GIP: helps your body respond to food, supporting weight loss

GIP is another hormone your body releases after food. It helps your body release insulin when needed and may work alongside GLP-1 to improve blood sugar control and appetite regulation.

Better insulin control results in fewer blood sugar spikes and crashes, which can help to reduce hunger and cravings. Your body is less likely to stay in a cycle of overeating driven by poor blood sugar control

Glucagon: can help the body burn more energy

Glucagon usually helps raise blood sugar when it drops too low, but it also seems to affect how the body uses energy and fat.

In retatrutide, glucagon activity appears to help the body use more energy, which means the body can burn more calories. This is one of the main reasons experts are interested in retatrutide, because it does more than just reducing appetite.

You can think of retatrutide as trying to do three jobs at the same time:

It can help reduce hunger

Like other medicines in this group, retatrutide works on the body’s natural appetite signals. This can help you feel less hungry, so eating less may feel more manageable.

It can help you feel fuller for longer

Part of the medicine can slow down how quickly food leaves your stomach. This means you may stay satisfied for longer after meals, which can make it easier to avoid snacking or overeating.

It can help improve blood sugar levels

In diabetes studies, retatrutide has been shown to improve blood sugar control as well as support weight loss. This means it may help the body handle sugar more effectively after eating.

It may help the body burn more energy

One part of retatrutide may also affect how the body uses energy and fat. In simple terms, researchers think it could help the body burn more calories, although this is still being studied.

Retatrutide does not produce its full effect overnight, but trial results suggest it starts having an effect fairly early, with the effects building over time.

In the phase 2 obesity trial published in The New England Journal of Medicine, weight loss was already measurable during the first part of treatment and continued to increase through 24 weeks and then 48 weeks.

Lilly also reported no weight-loss plateau through 40 weeks in a phase 3 diabetes trial news release, meaning people were still trending downward in weight at the end of that study period.

Retatrutide is being studied because it may do more than current single-pathway medicines by combining appetite reduction, fullness, blood sugar control and possibly higher energy expenditure in one weekly injection.

The key point for patients is that it seems to start working early but deliver its biggest results over time.

It is promising, but it is still an investigational medicine, so there is more to learn as data from clinical trials and studies is rolled out over the coming months.